Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Imaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical Overview.

Reva S, Nosov A, Novikov R, Petrov S.

Int Sch Res Notices. 2014 Jul 15;2014:243080. doi: 10.1155/2014/243080. eCollection 2014. Review.

2.

NUDT11 rs5945572 polymorphism and prostate cancer risk: a meta-analysis.

Li W, Gu M.

Int J Clin Exp Med. 2015 Mar 15;8(3):3474-81. eCollection 2015.

3.

Impact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk.

Kader AK, Liss MA, Trottier G, Kim ST, Sun J, Zheng SL, Chadwick K, Lockwood G, Xu J, Fleshner NE.

Urology. 2015 Jan;85(1):165-70. doi: 10.1016/j.urology.2014.07.081.

4.
5.

A comparison of Bayesian and frequentist approaches to incorporating external information for the prediction of prostate cancer risk.

Newcombe PJ, Reck BH, Sun J, Platek GT, Verzilli C, Kader AK, Kim ST, Hsu FC, Zhang Z, Zheng SL, Mooser VE, Condreay LD, Spraggs CF, Whittaker JC, Rittmaster RS, Xu J.

Genet Epidemiol. 2012 Jan;36(1):71-83. doi: 10.1002/gepi.21600.

6.

Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression.

FitzGerald LM, Zhang X, Kolb S, Kwon EM, Liew YC, Hurtado-Coll A, Knudsen BS, Ostrander EA, Stanford JL.

Hum Mutat. 2013 Jan;34(1):149-56. doi: 10.1002/humu.22176. Epub 2012 Oct 4.

7.

Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial.

Kader AK, Sun J, Reck BH, Newcombe PJ, Kim ST, Hsu FC, D'Agostino RB Jr, Tao S, Zhang Z, Turner AR, Platek GT, Spraggs CF, Whittaker JC, Lane BR, Isaacs WB, Meyers DA, Bleecker ER, Torti FM, Trent JM, McConnell JD, Zheng SL, Condreay LD, Rittmaster RS, Xu J.

Eur Urol. 2012 Dec;62(6):953-61. doi: 10.1016/j.eururo.2012.05.006. Epub 2012 May 12.

8.

Pooled sample-based GWAS: a cost-effective alternative for identifying colorectal and prostate cancer risk variants in the Polish population.

Gaj P, Maryan N, Hennig EE, Ledwon JK, Paziewska A, Majewska A, Karczmarski J, Nesteruk M, Wolski J, Antoniewicz AA, Przytulski K, Rutkowski A, Teumer A, Homuth G, Starzyńska T, Regula J, Ostrowski J.

PLoS One. 2012;7(4):e35307. doi: 10.1371/journal.pone.0035307. Epub 2012 Apr 19.

9.

Using graded response model for the prediction of prostate cancer risk.

Chen SH, Ip EH, Xu J, Sun J, Hsu FC.

Hum Genet. 2012 Aug;131(8):1327-36. doi: 10.1007/s00439-012-1160-8. Epub 2012 Mar 30.

10.

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.

Klein RJ, Hallden C, Gupta A, Savage CJ, Dahlin A, Bjartell A, Manjer J, Scardino PT, Ulmert D, Wallström P, Vickers AJ, Lilja H.

Eur Urol. 2012 Mar;61(3):471-7. doi: 10.1016/j.eururo.2011.10.047. Epub 2011 Nov 7.

11.

Lemur tyrosine kinase-2 signalling regulates kinesin-1 light chain-2 phosphorylation and binding of Smad2 cargo.

Manser C, Guillot F, Vagnoni A, Davies J, Lau KF, McLoughlin DM, De Vos KJ, Miller CC.

Oncogene. 2012 May 31;31(22):2773-82. doi: 10.1038/onc.2011.437. Epub 2011 Sep 26.

12.

Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.

Lin DW, FitzGerald LM, Fu R, Kwon EM, Zheng SL, Kolb S, Wiklund F, Stattin P, Isaacs WB, Xu J, Ostrander EA, Feng Z, Grönberg H, Stanford JL.

Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1928-36. doi: 10.1158/1055-9965.EPI-11-0236. Epub 2011 Aug 16.

13.

Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer.

Jin G, Sun J, Liu W, Zhang Z, Chu LW, Kim ST, Sun J, Feng J, Duggan D, Carpten JD, Wiklund F, Grönberg H, Isaacs WB, Zheng SL, Xu J.

Carcinogenesis. 2011 Jul;32(7):1057-62. doi: 10.1093/carcin/bgr082. Epub 2011 May 5.

14.

Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.

FitzGerald LM, Kwon EM, Conomos MP, Kolb S, Holt SK, Levine D, Feng Z, Ostrander EA, Stanford JL.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1196-203. doi: 10.1158/1055-9965.EPI-10-1299. Epub 2011 Apr 5.

15.

Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.

Penney KL, Schumacher FR, Kraft P, Mucci LA, Sesso HD, Ma J, Niu Y, Cheong JK, Hunter DJ, Stampfer MJ, Hsu SI.

Carcinogenesis. 2011 Jun;32(6):853-9. doi: 10.1093/carcin/bgr050. Epub 2011 Mar 18.

16.

Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.

Lindstrom S, Schumacher F, Siddiq A, Travis RC, Campa D, Berndt SI, Diver WR, Severi G, Allen N, Andriole G, Bueno-de-Mesquita B, Chanock SJ, Crawford D, Gaziano JM, Giles GG, Giovannucci E, Guo C, Haiman CA, Hayes RB, Halkjaer J, Hunter DJ, Johansson M, Kaaks R, Kolonel LN, Navarro C, Riboli E, Sacerdote C, Stampfer M, Stram DO, Thun MJ, Trichopoulos D, Virtamo J, Weinstein SJ, Yeager M, Henderson B, Ma J, Le Marchand L, Albanes D, Kraft P.

PLoS One. 2011 Feb 24;6(2):e17142. doi: 10.1371/journal.pone.0017142.

17.

Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.

Fesinmeyer MD, Kwon EM, Fu R, Ostrander EA, Stanford JL.

Prostate. 2011 Oct 1;71(14):1538-47. doi: 10.1002/pros.21370. Epub 2011 Feb 25.

18.

Impact of genotyping on outcome of prostatic biopsies: a multicenter prospective study.

Cornu JN, Drouin S, Cancel-Tassin G, Bigot P, Azzouzi AR, Koutlidis N, Cormier L, Gaffory C, Rouprêt M, Sèbe P, Bitker MO, Haab F, Cussenot O.

Mol Med. 2011 May-Jun;17(5-6):473-7. doi: 10.2119/molmed.2010.00205. Epub 2011 Feb 4.

19.

Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis.

Pomerantz MM, Shrestha Y, Flavin RJ, Regan MM, Penney KL, Mucci LA, Stampfer MJ, Hunter DJ, Chanock SJ, Schafer EJ, Chan JA, Tabernero J, Baselga J, Richardson AL, Loda M, Oh WK, Kantoff PW, Hahn WC, Freedman ML.

PLoS Genet. 2010 Nov 11;6(11):e1001204. doi: 10.1371/journal.pgen.1001204.

20.

Pesticide use modifies the association between genetic variants on chromosome 8q24 and prostate cancer.

Koutros S, Beane Freeman LE, Berndt SI, Andreotti G, Lubin JH, Sandler DP, Hoppin JA, Yu K, Li Q, Burdette LA, Yuenger J, Yeager M, Alavanja MC.

Cancer Res. 2010 Nov 15;70(22):9224-33. doi: 10.1158/0008-5472.CAN-10-1078. Epub 2010 Oct 26.

Supplemental Content

Support Center